Telum Therapeutics
Noáin, Spain
◆ About Telum Therapeutics
Develops treatments for hospital-acquired infections.
◆ What sets it apart
Uses proprietary metagenomic data, synthetic biology, and engineered lytic proteins to create precision antimicrobials against hard-to-treat hospital infections.
◆ Sectors
Digital HealthDrug Discoverysynthetic biologyantimicrobial resistance
◆ Business
Modeldrug development
CustomerHospitals, clinicians, and pharmaceutical partners developing or using treatments for severe multidrug-resistant bacterial infections
◆ Notable
- Raised €18 million Series A to advance its lead antimicrobial program into clinical development
- Advanced a lead candidate toward Phase 1 development for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
◆ Explore the market
◆ FAQ
What does Telum Therapeutics do?
Develops treatments for hospital-acquired infections.
Where is Telum Therapeutics based?
Telum Therapeutics is based in Noáin, Spain, founded in 2019.
Who has invested in Telum Therapeutics?
Investors in Telum Therapeutics include Morningside.